UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 AND
RULE 13a-17 OR 15d-17
THEREUNDER
ST. JUDE MEDICAL, INC.
-----------------------------------------
(Exact name or issuer as specified in charter)
ONE LILLEHEI PLAZA ST. PAUL, MINNESOTA 55117
-----------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code 612-483-2000
--------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% of more in the number of
shares outstanding:
1. Title of security COMMON STOCK ($.10 PAR VALUE)
-----------------------------------------
2. Number of shares outstanding before the change 46,647,090
-----------------------
3. Number of shares outstanding after the change 69,970,635
-----------------------
4. Effective date of change NOV. 2, 1995 - RECORD DATE, NOV. 16, 1995 -
PAYMENT DATE
--------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange,
distribution, stock split, reverse split, acquisition of
stock for treasury, etc.) STOCK SPLIT
-----------------------------
Give brief description of transaction A 50% STOCK DIVIDEND PAYABLE TO
------------------------------------
SHAREHOLDERS OF RECORD ON NOVEMBER 2, 1995
---------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
-----------------------------------------
2. Name after change
-----------------------------------------
3. Effective date of charter amendment changing name
----------------------
4. Date of shareholder approval of change, if required
----------------------
Date November 7, 1995 /s/ Stephen L. Wilson V.P. - Finance & CFO
----------------- --------------------------------------------
(Officer's signature & title)
